| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0735-1097(91)90714-K |
| P698 | PubMed publication ID | 1987214 |
| P2093 | author name string | Fitzpatrick AP | |
| Sutton R | |||
| Vardas P | |||
| Theodorakis G | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | syncope | Q180007 |
| tilt table test | Q1742390 | ||
| P304 | page(s) | 125-130 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Methodology of head-up tilt testing in patients with unexplained syncope | |
| P478 | volume | 17 |
| Q33153356 | A controlled trial of acute and long-term medical therapy in tilt-induced neurolly mediated syncope |
| Q33154881 | A new alcohol provocation head up tilt protocol in the patients with alcohol-related syncope |
| Q33173698 | Accelerometer Systolic Time Intervals as Fast-Response Sensors of Upright Posture in the Young |
| Q33160734 | An increased endothelial-independent vasodilation is the hallmark of the neurally mediated syncope. |
| Q72144037 | Are heart rate responses reproducible in the tilt-table test? |
| Q33163511 | Atrial electromechanical conduction delay in patients with neurocardiogenic syncope. |
| Q54237168 | Baroreceptor denervation presenting as part of a vagal mononeuropathy |
| Q33174633 | Can serial tilt testing be used to evaluate therapy in neurally mediated syncope? |
| Q91872271 | Cerebral Oximetry in Syncope and Syndromes of Orthostatic Intolerance |
| Q33175191 | Clinical approach to diagnosis of syncope. An Overview |
| Q33150581 | Clinical characteristics and head-up tilt test results with three protocols in 1661 patients with syncope |
| Q33149306 | Clinical findings as predictors of positivity of head-up tilt table test in neurocardiogenic syncope. |
| Q33153043 | Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004 |
| Q33154490 | Common patterns of response to the head-up tilt test in children and adolescents |
| Q33148066 | Comparison between isoproterenol and nitroglycerin sensitized head-upright tilt in patients with unexplained syncope and negative or positive passive head-up tilt response |
| Q33161385 | Comparison of a shortened isosorbide dinitrate-potentiated head-up tilt testing with the conventional protocol: tolerance and diagnostic accuracy |
| Q33145448 | Comparison of diagnostic accuracy of sublingual nitroglycerin test and low-dose isoproterenol test in patients with unexplained syncope |
| Q33175499 | Comparison of tilt angles and provocative agents (edrophonium and isoproterenol) to improve head-upright tilt-table testing |
| Q33146602 | Costs and utility of tests in the evaluation of the pediatric patients with syncope |
| Q33146022 | Determining the optimal pacing intervention rate for vasovagal syncope |
| Q33146002 | Diagnosis and management of neurally mediated syncope and related conditions in adolescents |
| Q30479371 | Diagnosis and management of patients with blackouts |
| Q33175793 | Diagnosis and treatment of vasovagal syncope in the child and adolescent |
| Q33146292 | Diagnostic accuracy of a protocol in the evaluation of unexplained syncope |
| Q33153167 | Diagnostic criteria for vasovagal syncope based on a quantitative history |
| Q33146208 | Diagnostic evaluation and management of patients with syncope |
| Q33174373 | Differences in circulatory control in normal subjects who faint and who do not faint during orthostatic stress |
| Q33144880 | Differences in heart rate variability between cardioinhibitory and vasodepressor responses to head-up tilt table testing. |
| Q33154909 | Discrepancy between head-up tilt test results utilizing different protocols in the same patient |
| Q33175247 | Does the Chronic Fatigue Syndrome Involve the Autonomic Nervous System? |
| Q78424081 | Effect of carotid sinus massage and tilt-table testing in a normal, healthy older population (The Healthy Ageing Study) |
| Q33145684 | Effects of intravenous etilefrine in neurocardiogenic syncope induced by head-up tilt testing |
| Q33144644 | Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. |
| Q33154312 | Evaluation of syncope: an overview |
| Q33173644 | Evolution of patients with clinical neurocardiogenic (vasovagal) syncope not subjected to specific treatment |
| Q33174060 | Exercise induced vasodepressor syncope |
| Q35374793 | Haemodynamic effects of increasing angle of head up tilt |
| Q33168632 | Head Up Tilt Testing: An Appraisal of Its Current Role in the Management of Patients with Syncope |
| Q33174982 | Head-up tilt table test: how far and how long? |
| Q33165199 | Head-up tilt table testing with sublingual isosorbide dinitrate in the diagnosis of vasovagal syncope in children |
| Q33174893 | Head-up tilt test with isoproterenol provocation in syncope of unknown origin |
| Q33146764 | Head-up tilt test without intravascular cannulation in children and adolescents |
| Q33175576 | Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: a simplified time-saving approach for the evaluation of unexplained syncope. |
| Q33173964 | Head-up tilt testing. The balance of evidence |
| Q71596779 | Head-up tilt testing: do we need to give an added push? |
| Q33174316 | Head-upright tilt table testing for recurrent, unexplained syncope |
| Q33173720 | Head‐Up Tilt Testing With and Without Isoproterenol Infusion in Healthy Subjects of Different Ages |
| Q33149020 | Heart Rate Variability in Patients with Vasovagal Syndrome |
| Q33164889 | Heart rate variability analysis during head-up tilt test predicts nitroglycerine-induced syncope |
| Q64120903 | Hemodynamic Response to the Head-Up Tilt Test in Patients With Syncope as a Predictor of the Test Outcome: A Meta-Analysis Approach |
| Q48201822 | Hemodynamic parameters and baroreflex sensitivity during head-up tilt test in patients with neurally mediated syncope. |
| Q33147868 | Historical criteria that distinguish syncope from seizures |
| Q37843759 | Human and Monkey Prolactin and Growth Hormone: Separation of Polymorphic Forms by Isoelectric Focusing1 |
| Q33175442 | Immediate reproducibility of tilt-table test results in elderly patients referred for evaluation of syncope or presyncope |
| Q104137092 | Impaired cerebral oxygenation in heart failure patients at rest and during head-up tilt testing |
| Q54961948 | Improved Patient Outcomes by Normalizing Sympathovagal Balance: Differentiating Syncope-Precise Subtype Differentiation Leads to Improved Outcomes. |
| Q33149015 | Incidence and Predictors of Syncope in Paced Patients with Sick Sinus Syndrome |
| Q33174027 | Increase in plasma beta endorphins precedes vasodepressor syncope |
| Q33144514 | Increased orthostatic tolerance following moderate exercise training in patients with unexplained syncope |
| Q33145112 | Indications, methodology, and classification of results of tilt-table testing |
| Q24804814 | Influence of passive leg movements on blood circulation on the tilt table in healthy adults |
| Q33153184 | Lack of variation in venous tone potentiates vasovagal syncope |
| Q33175325 | Long-term prognosis of patients with syncope of unknown origin in prolonged asystole induced by the head-up tilt test |
| Q24569640 | Management and therapy of vasovagal syncope: A review |
| Q33173636 | Mechanisms of syncope caused by transient bradycardia and the diagnostic value of electrophysiologic testing and cardiovascular reflexivity maneuvers |
| Q33168472 | Myocardial Performance Index in Neurocardiogenic Syncope Patients |
| Q33163880 | Natriuretic peptides in the evaluation of syncope in children and adolescents |
| Q33146854 | Neurocardiogenic syncope: aetiology and management |
| Q33165160 | Oral rehydration salts: an effective choice for the treatment of children with vasovagal syncope |
| Q33159958 | Orthostatic hypotension : diagnosis and therapy |
| Q50489561 | Orthostatic tolerance and blood volumes in Andean high altitude dwellers. |
| Q33173900 | Orthostatic tolerance in patients with unexplained syncope |
| Q33145324 | Pacing to prevent vasovagal syncope |
| Q33174143 | Permanent pacing for cardioinhibitory malignant vasovagal syndrome |
| Q33148868 | Predictors of Positive Head‐Up Tilt Test in Patients with Suspected Neurocardiogenic Syncope or Presyncope |
| Q33175051 | Prospective evaluation of high-dose or low-dose isoproterenol upright tilt protocol for unexplained syncope in young adults |
| Q33146759 | Prospective evaluation of patients with syncope: a population-based study |
| Q71970821 | Provocation of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Comparison of orthostasis testing and nitrate application |
| Q33145120 | Putting it together: a new treatment algorithm for vasovagal syncope and related disorders |
| Q33150041 | Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management |
| Q33165242 | Relationship between Neurocardiogenic Syncope and Ventricular Repolarization. |
| Q33174675 | Reproducibility of head-up tilt test in patients with syncope |
| Q28373169 | Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope |
| Q33153032 | Reproducibility of head-up tilt-table testing in pediatric patients with neurocardiogenic syncope |
| Q33174624 | Reproducibility of orthostatic hypotension in symptomatic elderly |
| Q33148743 | Reproducibility of the head-up tilt test results in children with vasovagal syncope |
| Q33175222 | Reproducibility of time-domain indexes of heart rate variability in patients with vasovagal syncope |
| Q33175913 | Review article: heart rate and blood pressure control in vasovagal syncope |
| Q33175614 | Role of adenosine triphosphate (ATP) in head-up tilt-induced syncope |
| Q33148106 | Role of echocardiography in the evaluation of syncope: a prospective study |
| Q33146931 | Role of endogenous adenosine in vasovagal syncope |
| Q33175925 | Role of endogenous opioids in syncope induced by head-up tilt test and its relationship with isoproterenol-dependent and isoproterenol-independent neurally-mediated syncope |
| Q33174674 | Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope |
| Q33167053 | Self-Organization of Blood Pressure Regulation: Clinical Evidence |
| Q36747082 | Self-Organization of Blood Pressure Regulation: Experimental Evidence |
| Q50573629 | Sex and age effects on cardiovascular autonomic function in healthy adults. |
| Q33175575 | Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. |
| Q33175365 | Specificity of head-up tilt testing in adolescents: effect of various degrees of tilt challenge in normal control subjects |
| Q33175718 | Spectral analysis of heart rate variability during tilt-table testing in patients with vasovagal syncope |
| Q33147724 | Strategy for the management of vasovagal syncope |
| Q72521685 | Syncope |
| Q81651244 | Syncope |
| Q33174145 | Syncope in older persons |
| Q33175173 | Syncope: current diagnosis and treatment |
| Q33147994 | Syncope: investigation and treatment |
| Q33175303 | Systolic blood pressure at rest, not the degree of beta blockade, predicts the result of follow-up tilt-table testing for vasovagal syncope |
| Q33162357 | T-peak to T-end abnormality in pediatric patients with syncope |
| Q33154686 | The Etiology of Syncope in Pacemaker Patients |
| Q33145419 | The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders |
| Q59126283 | The complexity of hemodynamic response to the tilt test with and without nitroglycerine provocation in patients with vasovagal syncope |
| Q33146205 | The fainting patient: value of the head-upright tilt-table test in adult patients with orthostatic intolerance |
| Q33145829 | The normal response to prolonged passive head up tilt testing |
| Q33164494 | The role of NT-proBNP in the diagnostics and differentiation of cardiac and reflex syncope in adults: relative importance to clinical presentation and medical examinations |
| Q33144642 | The tilt-table test in assessing syncope of unknown origin: do differences exist between children and adults? |
| Q33175354 | The tilt-table test: is it essential for adequate treatment of vasovagal syncope? Arguments against |
| Q33174834 | The yield of head-up tilt testing is not significantly increased by repeating the baseline test |
| Q33173534 | Tilt table evaluation for control pediatric patients: comparison with symptomatic patients |
| Q34805659 | Tilt table test: state of the art. |
| Q52562420 | Tilt table testing for syncope and collapse. |
| Q33166328 | Tilt testing results are influenced by tilt protocol |
| Q33162888 | Tilt-table test: its role in modern practice. |
| Q33174751 | Transcranial Doppler during neurocardiogenic syncope |
| Q33163806 | Transient aphasia: a rare complication of head-up tilt test. |
| Q33164469 | Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis |
| Q33145887 | Usefulness of clinical factors in predicting outcomes of passive tilt tests in patients with syncope |
| Q33144994 | Usefulness of tilt test-induced patterns of heart rate and blood pressure using a two-stage protocol with glyceryl trinitrate provocation in patients with syncope of unknown origin |
| Q33144580 | Utility of a single-stage isoproterenol tilt table test in adults: a randomized comparison with passive head-up tilt |
| Q33173635 | Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope |
| Q33144637 | Value of sublingual isosorbide dinitrate before isoproterenol tilt test for diagnosis of neurally mediated syncope |
| Q33144841 | Vasovagal syncope in heart transplant patients during dental surgery |
| Q33173705 | Workup and management of patients with syncope |
| Q33149206 | [Effect of time elapsed from spontaneous syncope on the diagnostic performance of the head-up tilt table test]. |
| Q84486967 | [Electrophysiologic diagnosis and therapy] |
Search more.